查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496918

药品契约製造市场：趋势、机会与竞争分析 [2024-2030]

Pharmaceutical Contract Manufacturing Market: Trends, Opportunities and Competitive Analysis [2024-2030]
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

药品契约製造市场的趋势与预测

预计到 2030 年，全球药品契约製造市场将达到 2,984 亿美元，2024 年至 2030 年复合年增长率为 7.9%。该市场的主要驱动力是对学名药和专科药物的需求不断增长、药品研发活动投资的增加以及寻求「一站式」效益的 CMO（契约製造组织）的成长趋势。全球医药契约製造市场的未来前景广阔，大型製药公司、小型製药公司和学名药市场都有机会。

药品契约製造市场洞察

  • Lucintel 预计，由于生产疫苗和生物相似药的需求不断增长，生技药品製造在预测期内仍将是最大的细分市场。
  • 市场上大型药局外包药品生产以尽量减少价格压力和管道问题的趋势日益明显，随着畅销药物专利到期，对成本优化的需求也不断增加。
  • 由于人口老化带来的需求增加、外包活动的增加以及该地区主要企业製造能力的扩大，预计亚太地区仍将是最大的地区。

常问问题

Q1.市场规模为：

答：到2030年，全球药品契约製造市场预计将达到2,984亿美元。

Q2.市场成长预测是多少：

答：2024年至2030年，全球药品契约製造市场预期复合年增长率为7.9%。

Q3.影响市场成长的主要驱动因素是：

答：这个市场的主要驱动力是学名药需求的成长、药品研发活动投资的增加以及CMO（契约製造组织）寻求「一站式」效益的趋势。

Q4.市场的主要细分市场是：

答：医药契约製造市场前景广阔，大药厂、小药厂、学名药市场都有机会。

Q5. 主要的药品契约製造公司有哪些？

答：主要药品契约製造企业如下：

  • Thermo Fisher Scientific
  • Catalent
  • Lonza
  • Almac Group
  • Recipharm
  • Patheon
  • Grifols International
  • Dalton Pharma Services
  • AbbVie

Q6. 未来哪个医药契约製造领域将是最大的？

答：Lucintel 预计，由于生产疫苗和生物相似药的需求不断增长，生技药品製造在预测期内仍将是最大的细分市场。

Q7.未来五年预计哪些地区的市场成长最大？

答：由于人口老化带来的需求增加、外包活动的增加以及该地区主要企业製造能力的扩大，预计亚太地区仍将是最大的地区。

Q8. 可以客製化报告吗？

答：是的，Lucintel 提供 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章全球药品契约製造市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球药品契约製造市场趋势（2018-2023）与预测（2024-2030）
  • 按服务分類的全球药品契约製造市场
    • 製造业
      • API
      • FDF（注射剂、锭剂、胶囊、口服液）
    • 医药开发
    • 生技药品製造
  • 按最终用途行业分類的全球药品契约製造市场
    • 大型製药公司
    • 中小医药
    • 学名药
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的药品契约製造市场
  • 北美药品契约製造市场
  • 欧洲药品契约製造市场
  • 亚太地区药品契约製造市场
  • 其他地区药品契约製造市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球药品契约製造市场的成长机会（按服务划分）
    • 最终用途产业全球药品契约製造市场的成长机会
    • 按地区分類的全球药品契约製造市场成长机会
  • 全球药品契约製造市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球药品契约製造市场的产能
    • 全球药品契约製造市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Thermo Fisher Scientific
  • Catalent
  • Lonza
  • Almac Group
  • Recipharm
  • Patheon
  • Grifols International
  • Dalton Pharma Services
  • AbbVie
简介目录

Pharmaceutical Contract Manufacturing Market Trends and Forecast

The future of the global pharmaceutical contract manufacturing market looks promising with opportunities in the big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical markets. The global pharmaceutical contract manufacturing market is expected to reach an estimated $298.4 billion by 2030 with a CAGR of 7.9% from 2024 to 2030. The major drivers for this market are growing demand for generic and specialty medicines, increasing investments in pharmaceutical R&D activities, and rising trend for CMOs (contract manufacturing organization) for "one-stop-shop" benefit.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Pharmaceutical Contract Manufacturing Market by Segment

The study includes a forecast for the global pharmaceutical contract manufacturing market by services, end use industry, and region, as follows:

Pharmaceutical Contract Manufacturing Market by Services [Value ($B) Shipment Analysis from 2018 to 2030]:

  • Manufacturing
    • API
    • FDF (Parenteral, Injectable, Tablet, Capsule, and Oral Liquid)
  • Drug Development
  • Biologics Manufacturing

Pharmaceutical Contract Manufacturing Market by End Use Industry [Value ($B) Shipment Analysis from 2018 to 2030]:

  • Big Pharmaceutical
  • Small & Medium-Sized Pharmaceutical
  • Generic Pharmaceutical
  • Others

Pharmaceutical Contract Manufacturing Market by Region [Value ($B) Shipment Analysis from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pharmaceutical Contract Manufacturing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pharmaceutical contract manufacturing companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pharmaceutical contract manufacturing companies profiled in this report include.

  • Thermo Fisher Scientific
  • Catalent
  • Lonza
  • Almac Group
  • Recipharm
  • Patheon
  • Grifols International
  • Dalton Pharma Services
  • AbbVie

Pharmaceutical Contract Manufacturing Market Insights

  • Lucintel forecasts that biologics manufacturing will remain the largest segment over the forecast period due to increasing need for producing vaccines and biosimilars.
  • Within this market, big pharmaceutical segment is expected to remain the largest segment due to growing trend among large pharmacies to contract out pharmaceutical production in order to minimize the pricing pressure and pipeline issues in their operations along with increasing demand for optimization of execution costs as bestselling medication patents expires.
  • APAC is expected to remain the largest region due to increasing demand from geriatric population, growing outsourcing activities and expansion of manufacturing capabilities of the local key players in the region.

Features of the Pharmaceutical Contract Manufacturing Market

  • Market Size Estimates: Pharmaceutical contract manufacturing market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments and regions.
  • Segmentation Analysis: Pharmaceutical contract manufacturing market size by various segments, such as by services, end use industry, and region
  • Regional Analysis: Pharmaceutical contract manufacturing market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different by services, end use industry, and regions for the pharmaceutical contract manufacturing market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the pharmaceutical contract manufacturing market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the pharmaceutical contract manufacturing market size?

Answer: The global pharmaceutical contract manufacturing market is expected to reach an estimated $298.4 billion by 2030.

Q2. What is the growth forecast for pharmaceutical contract manufacturing market?

Answer: The global pharmaceutical contract manufacturing market is expected to grow with a CAGR of 7.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the pharmaceutical contract manufacturing market?

Answer: The major drivers for this market are growing demand for generic and specialty medicines, increasing investments in pharmaceutical R&D activities, and rising trend for CMOs (contract manufacturing organization) for "one-stop-shop" benefit.

Q4. What are the major segments for pharmaceutical contract manufacturing market?

Answer: The future of the pharmaceutical contract manufacturing market looks promising with opportunities in the big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical markets.

Q5. Who are the key pharmaceutical contract manufacturing companies?

Answer: Some of the key pharmaceutical contract manufacturing companies are as follows:

  • Thermo Fisher Scientific
  • Catalent
  • Lonza
  • Almac Group
  • Recipharm
  • Patheon
  • Grifols International
  • Dalton Pharma Services
  • AbbVie

Q6. Which pharmaceutical contract manufacturing segment will be the largest in future?

Answer:Lucintel forecasts that biologics manufacturing will remain the largest segment over the forecast period due to increasing need for producing vaccines and biosimilars.

Q7. In pharmaceutical contract manufacturing market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to remain the largest region due to increasing demand from geriatric population, growing outsourcing activities and expansion of manufacturing capabilities of the local key players in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1. What are some of the most promising, high-growth opportunities for the pharmaceutical contract manufacturing market by services (manufacturing [API, FDF (parenteral, injectable, tablet, capsule, and oral liquid)], drug development, and biologics manufacturing), end use industry (big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity did occur in the last five years and how did they impact the industry?

Table of Contents

1. Executive Summary

2. Global Pharmaceutical Contract Manufacturing Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1: Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2: Global Pharmaceutical Contract Manufacturing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pharmaceutical Contract Manufacturing Market by Services
    • 3.3.1: Manufacturing
      • 3.3.1.1: API
      • 3.3.1.2: FDF (Parenteral, Injectable, Tablet, Capsule, and Oral Liquid)
    • 3.3.2: Drug Development
    • 3.3.3: Biologics Manufacturing
  • 3.4: Global Pharmaceutical Contract Manufacturing Market by End Use Industry
    • 3.4.1: Big Pharmaceutical
    • 3.4.2: Small & Medium-Sized Pharmaceutical
    • 3.4.3: Generic Pharmaceutical
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Pharmaceutical Contract Manufacturing Market by Region
  • 4.2: North American Pharmaceutical Contract Manufacturing Market
    • 4.2.1: North American Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
    • 4.2.2: North American Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
  • 4.3: European Pharmaceutical Contract Manufacturing Market
    • 4.3.1: European Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
    • 4.3.2: European Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
  • 4.4: APAC Pharmaceutical Contract Manufacturing Market
    • 4.4.1: APAC Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
    • 4.4.2: APAC Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
  • 4.5: ROW Pharmaceutical Contract Manufacturing Market
    • 4.5.1: ROW Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
    • 4.5.2: ROW Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pharmaceutical Contract Manufacturing Market by Services
    • 6.1.2: Growth Opportunities for the Global Pharmaceutical Contract Manufacturing Market by End Use Industry
    • 6.1.3: Growth Opportunities for the Global Pharmaceutical Contract Manufacturing Market by Region
  • 6.2: Emerging Trends in the Global Pharmaceutical Contract Manufacturing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pharmaceutical Contract Manufacturing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pharmaceutical Contract Manufacturing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Catalent
  • 7.3: Lonza
  • 7.4: Almac Group
  • 7.5: Recipharm
  • 7.6: Patheon
  • 7.7: Grifols International
  • 7.8: Dalton Pharma Services
  • 7.9: AbbVie